Globus Medical Inc (GMED)
81.13
-1.41
(-1.71%)
USD |
NYSE |
Nov 14, 16:00
81.13
0.00 (0.00%)
After-Hours: 20:00
Globus Medical Research and Development Expense (Quarterly): 35.38M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 35.38M |
| June 30, 2024 | 37.70M |
| March 31, 2024 | 57.27M |
| December 31, 2023 | 52.25M |
| September 30, 2023 | 29.33M |
| June 30, 2023 | 21.35M |
| March 31, 2023 | 21.08M |
| December 31, 2022 | 19.51M |
| September 30, 2022 | 18.70M |
| June 30, 2022 | 17.40M |
| March 31, 2022 | 17.41M |
| December 31, 2021 | 51.02M |
| September 30, 2021 | 15.85M |
| June 30, 2021 | 15.55M |
| March 31, 2021 | 14.92M |
| December 31, 2020 | 15.24M |
| September 30, 2020 | 14.42M |
| June 30, 2020 | 39.46M |
| March 31, 2020 | 15.40M |
| December 31, 2019 | 15.50M |
| September 30, 2019 | 14.51M |
| June 30, 2019 | 15.75M |
| March 31, 2019 | 14.32M |
| December 31, 2018 | 13.76M |
| September 30, 2018 | 15.53M |
| Date | Value |
|---|---|
| June 30, 2018 | 13.52M |
| March 31, 2018 | 12.69M |
| December 31, 2017 | 11.41M |
| September 30, 2017 | 10.89M |
| June 30, 2017 | 10.71M |
| March 31, 2017 | 10.67M |
| December 31, 2016 | 13.64M |
| September 30, 2016 | 10.26M |
| June 30, 2016 | 10.59M |
| March 31, 2016 | 10.03M |
| December 31, 2015 | 9.672M |
| September 30, 2015 | 9.25M |
| June 30, 2015 | 9.081M |
| March 31, 2015 | 8.656M |
| December 31, 2014 | 7.883M |
| September 30, 2014 | 8.146M |
| June 30, 2014 | 7.694M |
| March 31, 2014 | 7.443M |
| December 31, 2013 | 6.418M |
| September 30, 2013 | 6.568M |
| June 30, 2013 | 7.037M |
| March 31, 2013 | 6.847M |
| December 31, 2012 | 7.228M |
| September 30, 2012 | 7.022M |
| June 30, 2012 | 6.94M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
14.42M
Minimum
Sep 2020
57.27M
Maximum
Mar 2024
26.24M
Average
19.10M
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp | 407.00M |
| ResMed Inc | 79.52M |
| Stryker Corp | 377.00M |
| Abbott Laboratories | 713.00M |
| Haemonetics Corp | 16.53M |